Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") announced the voting ...

Innate immune cells are white blood cells that mediate innate immunity and include basophils ... neutrophils and NK cells. Genes in transcription factor families presumably arose to accommodate ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that members of its executive team will present and host 1x1 meetings at the upcoming ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") announced today that four abstracts with Innate's drugs in clinical development have been accepted for the American ...

LIfT BioSciences presents latest data on its first-in-class Immunomodulatory Alpha Neutrophils at International Society for ...

Fintel reports that on May 20, 2025, Piper Sandler upgraded their outlook for ImmunityBio (NasdaqGS:IBRX) from Neutral to ...

Click here to register for the event. A live webcast of the fireside chat will be accessible on the Events page under the ...

Three innovative approaches to treating infections, fighting cancer, and enhancing the body's immune system have been ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Replimune Group shares fell 28% on heavy volume with no news, despite a promising July 2025 PDUFA date for RP1 in advanced ...

Novel combination with efti has met the trial's primary endpoint of tumour hyalinization/fibrosis in the neoadjuvant setting for patients with resectable soft tissue sarcomaDetailed results are planne ...